Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose,
crossover oral bioequivalence study of Omeprazole Magnesium 20 mg DR capsules of Dr. Reddy's
Laboratories Limited, India and Prilosec OTCTM 20 mg (Omeprazole Magnesium DR Tablets)of
Procter and Gamble, Cincinnati, Sweden in 38 healthy, adult, human subjects under fed
conditions.